PolymarketComprobar disponibilidadSin KYC2% de comisiónDatos de resolución verificadosCalibración aceptableProbabilidad implícita actualDecember 62%-0.5pt
Calidad del mercado
42 / 100
Baja calidadVolumen 24h
87,9 €
Liquidez
691,1 €
Baja liquidezCompra / Venta
21.0% / 25.0%
Spread
4.0 pt
Spread moderadoCambio 7d
-4.0 pts
Datos de mercado
Actualizado hace 23 minutos
23 jun 26, 2:1331 dic 26, 23:59
Tendencias
Solo fondos simulados, sin dinero realNo es asesoramiento financiero
Resultado elegido
December62%
Tendencia de volumen
$1003 jul18d de datos28 jul
Mercados Relacionados
When "Will Masking Return"? (widespread mask mandates in the USA)
995,9 €September 2023: 1%MANIFOLD MARKETS
MANIFOLD MARKETSWill the NIH indirect cost cap stick?
878,8 €Sí: 11.4%MANIFOLD MARKETS
MANIFOLD MARKETSWill George W Bush outlive Obama?
453,4 €Sí: 12.3%MANIFOLD MARKETS
MANIFOLD MARKETS
California Clinic Funding Proposition
43,9 €Sí: 34%POLYMARKET
POLYMARKET
Who will Trump announce as next FDA commissioner?
39,4 €No announcement by December 31: 41%POLYMARKET
POLYMARKET
What will the average number of measles cases be during Trump's term?
19,6 €At least 4500: 43%
KALSHI
KALSHIActivos en estos temas
Noticias Relacionadas
Polymarket: Vance leads 2028 at 19.85% as pricing trend softensBlockchain.News
White House pushes Senate Democrats to take 'historic' crypto Clarity Act ethics dealCoindesk
Senate nears bipartisan CLARITY Act deal after ethics breakthroughCrypto News
White House agrees to ethics provisions in market structure billCointelegraph
Polymarket odds show Vance at 19.85% as Epstein files critique hits tapeBlockchain.News
Dick Durbin accuses Todd Blanche of shielding Trump’s crypto empireCrypto NewsReglas
This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET.
- Otherwise, this market will resolve to “No”.
- A qualifying announcement must be official and public.
- Any rumored or private statements of intention will not qualify.
- Any announcement that the drug has been reclassified to Category 1 will qualify.
- Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date.